Antimicrobial resistance (AMR) is a global threat, particularly given the modest activity in the pipeline of...
OPINION
Experts Point of View
According to the FMD 2011/62, serialisation of all prescription drug packs in Europe will inevitably become a...
In February, Johnson & Johnson Innovation, JLABS opened its first European open innovation incubator, JLABs @...
Big Pharma’s interest in R&D on anti-infectives declined when other areas like oncology began offering higher...
Back in February 2017, CDMO Rentschler Biopharma SE and formulation specialist Leukocare AG joined forces to...
Following last year’s approval by the US FDA, the EU’s EMA has now also approved the first two T-cell-based...
Share
